A Phase 3, Multicenter, Double-Masked, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects with Neovascular Age- Related Macular Degeneration
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Ocular Therapeutix Inc
Start Date
March 13, 2025
End Date
March 14, 2030
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Ocular Therapeutix Inc
Start Date
March 13, 2025
End Date
March 14, 2030